The NCAN gene: schizophrenia susceptibility and cognitive dysfunction.

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Cognitive dysfunction is a key feature of schizophrenia.
• Understanding its neurobiological basis is crucial for identifying disease mechanisms.
• The neurocan gene (NCAN) rs1064395 polymorphism has been linked to schizophrenia in European populations and may affect brain structure.

Purpose of the Study:

• To investigate if the NCAN rs1064395 polymorphism is associated with schizophrenia risk and cognitive dysfunction in the Han Chinese population.
• To explore the relationship between this genetic variant and neuropsychological performance.

Main Methods:

• A case-control study involving 681 schizophrenia patients and 699 healthy controls.
• Neuropsychological assessment using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in 254 patients.
• Genotyping for the NCAN rs1064395 polymorphism and expression quantitative trait loci (eQTL) analysis.

Main Results:

• No significant differences in genotype or allele frequencies of rs1064395 between schizophrenia patients and controls.
• Schizophrenia patients exhibited significantly poorer performance across multiple cognitive domains compared to controls.
• Patients with rs1064395 A/A or A/G genotypes showed lower scores in immediate memory, visuospatial skills, attention, and overall RBANS performance compared to G/G genotype.
• eQTL analysis revealed a significant association between rs1064395 and NCAN gene expression in the frontal and cerebellar cortex.

Conclusions:

• The NCAN rs1064395 polymorphism may contribute to cognitive dysfunction in schizophrenia patients, independent of overall schizophrenia risk.
• Further research is needed to validate these findings and elucidate the precise mechanisms linking rs1064395 to cognitive deficits in schizophrenia.